UBS Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.16M | Sell |
1,640,099
-1,531,447
| -48% | -$2.74M | ﹤0.01% | 4899 |
|
|
2025
Q4 | $5.93M | Buy |
3,171,546
+1,674,320
| +112% | +$3.22M | ﹤0.01% | 3852 |
|
|
2025
Q3 | $1.92M | Sell |
1,497,226
-495,932
| -25% | -$672K | ﹤0.01% | 4994 |
|
|
2025
Q2 | $2.47M | Sell |
1,993,158
-291,120
| -13% | -$336K | ﹤0.01% | 4593 |
|
|
2025
Q1 | $2.7M | Buy |
2,284,278
+798,263
| +54% | +$1.22M | ﹤0.01% | 4426 |
|
|
2024
Q4 | $2.72M | Buy |
1,486,015
+843,166
| +131% | +$1.65M | ﹤0.01% | 4424 |
|
|
2024
Q3 | $1.09M | Sell |
642,849
-186,285
| -22% | -$306K | ﹤0.01% | 4579 |
|
|
2024
Q2 | $1.14M | Buy |
829,134
+151,881
| +22% | +$307K | ﹤0.01% | 4306 |
|
|
2024
Q1 | $2.54M | Buy |
677,253
+643,359
| +1,898% | +$3.77M | ﹤0.01% | 3707 |
|
|
2023
Q4 | $333K | Buy |
33,894
+11,247
| +50% | +$92K | ﹤0.01% | 5422 |
|
|
2023
Q3 | $189K | Sell |
22,647
-207,435
| -90% | -$2.37M | ﹤0.01% | 5405 |
|
|
2023
Q2 | $3.06M | Buy |
230,082
+193,508
| +529% | +$2.35M | ﹤0.01% | 3087 |
|
|
2023
Q1 | $424K | Sell |
36,574
-16,261
| -31% | -$162K | ﹤0.01% | 4820 |
|
|
2022
Q4 | $432K | Sell |
52,835
-27,350
| -34% | -$236K | ﹤0.01% | 4835 |
|
|
2022
Q3 | $465K | Buy |
80,185
+40,554
| +102% | +$233K | ﹤0.01% | 4399 |
|
|
2022
Q2 | $175K | Sell |
39,631
-57,591
| -59% | -$350K | ﹤0.01% | 5029 |
|
|
2022
Q1 | $885K | Sell |
97,222
-2,760
| -3% | -$31.8K | ﹤0.01% | 4224 |
|
|
2021
Q4 | $2.05M | Sell |
99,982
-9,570
| -9% | -$231K | ﹤0.01% | 3717 |
|
|
2021
Q3 | $2.8M | Sell |
109,552
-45,756
| -29% | -$1.36M | ﹤0.01% | 3263 |
|
|
2021
Q2 | $5.43M | Buy |
155,308
+68,428
| +79% | +$1.99M | ﹤0.01% | 2588 |
|
|
2021
Q1 | $2.89M | Buy |
86,880
+3,996
| +5% | +$140K | ﹤0.01% | 3178 |
|
|
2020
Q4 | $2.15M | Buy |
82,884
+45,079
| +119% | +$766K | ﹤0.01% | 3345 |
|
|
2020
Q3 | $373K | Buy |
37,805
+3,165
| +9% | +$18.2K | ﹤0.01% | 4388 |
|
|
2020
Q2 | $119K | Sell |
34,640
-112,842
| -77% | -$384K | ﹤0.01% | 5163 |
|
|
2020
Q1 | $451K | Sell |
147,482
-1,013,463
| -87% | -$4.15M | ﹤0.01% | 4067 |
|
|
2019
Q4 | $5.97M | Sell |
1,160,945
-424,207
| -27% | -$2.16M | ﹤0.01% | 2447 |
|
|
2019
Q3 | $8.18M | Sell |
1,585,152
-64,858
| -4% | -$363K | ﹤0.01% | 1933 |
|
|
2019
Q2 | $9.98M | Buy |
1,650,010
+102,516
| +7% | +$719K | ﹤0.01% | 1756 |
|
|
2019
Q1 | $11.2M | Sell |
1,547,494
-371,679
| -19% | -$2.69M | 0.01% | 1591 |
|
|
2018
Q4 | $14.2M | Buy |
1,919,173
+1,428,246
| +291% | +$9.05M | 0.01% | 1323 |
|
|
2018
Q3 | $2.66M | Buy |
490,927
+100,111
| +26% | +$430K | ﹤0.01% | 2951 |
|
|
2018
Q2 | $1.39M | Buy |
390,816
+89,090
| +30% | +$247K | ﹤0.01% | 3490 |
|
|
2018
Q1 | $619K | Buy |
301,726
+127,112
| +73% | +$330K | ﹤0.01% | 4064 |
|
|
2017
Q4 | $461K | Sell |
174,614
-100,687
| -37% | -$353K | ﹤0.01% | 4351 |
|
|
2017
Q3 | $1.45M | Buy |
275,301
+162,066
| +143% | +$697K | ﹤0.01% | 3396 |
|
|
2017
Q2 | $403K | Sell |
113,235
-266
| -0.2% | -$1.07K | ﹤0.01% | 4269 |
|
|
2017
Q1 | $586K | Sell |
113,501
-5,712,291
| -98% | -$28M | ﹤0.01% | 3931 |
|
|
2016
Q4 | $22.1M | Buy |
5,825,792
+5,745,024
| +7,113% | +$41.7M | 0.02% | 960 |
|
|
2016
Q3 | $724K | Sell |
80,768
-32,630
| -29% | -$273K | ﹤0.01% | 3646 |
|
|
2016
Q2 | $798K | Buy |
113,398
+105,880
| +1,408% | +$967K | ﹤0.01% | 3566 |
|
|
2016
Q1 | $64K | Sell |
7,518
-2,253
| -23% | -$22.2K | ﹤0.01% | 5305 |
|
|
2015
Q4 | $128K | Buy |
9,771
+3,556
| +57% | +$31.9K | ﹤0.01% | 5019 |
|
|
2015
Q3 | $22K | Sell |
6,215
-2,961
| -32% | -$14.5K | ﹤0.01% | 6612 |
|
|
2015
Q2 | $53K | Buy |
9,176
+5,976
| +187% | +$34.6K | ﹤0.01% | 5962 |
|
|
2015
Q1 | $19K | Buy |
3,200
+700
| +28% | +$4.83K | ﹤0.01% | 7041 |
|
|
2014
Q4 | $20K | Buy |
+2,500
| New | +$16K | ﹤0.01% | 7677 |
|
Other funds holding PACB
AIM
VCM
NAMA
